What is FibroBiologics, Inc. Common Stock (FBLG) stock price today?

FibroBiologics, Inc. Common Stock (FBLG) currently trades at $1.32 per share. The stock has a market capitalization of $6.45M and a P/E ratio of —x.

Is FBLG stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, FibroBiologics, Inc. Common Stock has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -5.03.

Is FibroBiologics, Inc. Common Stock financially healthy?

FibroBiologics, Inc. Common Stock's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -5.03 places it in the distress.

FBLG

FibroBiologics, Inc. Common Stock

NASDAQ: FBLG · HEALTHCARE · BIOTECHNOLOGY

$1.32

+0.76% today

Updated 2026-04-30

Market cap

$6.45M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-8.40

Dividend yield

—

52W range

$1 – $23

Volume

1.0M

Market cap

$6.45M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-8.40

Dividend yield

—

52W range

$1 – $23

Volume

1.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

2.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-5.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$19.00

+1339.39%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -5.03 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-3.16M

- Debt/equity 56.90x — high leverage

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-1.58M	$-5.12M	$-16.48M	$-11.16M	$-3.24M
EPS	—	—	—	—	$-8.40
Free cash flow	$-1.41M	$-4.07M	$-6.90M	$-12.09M	$-3.16M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FBLG	$6.45M	23	4.3	3.0	5.0	2.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

FibroBiologics, Inc. Common Stock trades at $1.32. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -5.03, it sits in the distress.

Frequently asked questions

What is FibroBiologics, Inc. Common Stock's stock price?

FibroBiologics, Inc. Common Stock (FBLG) trades at $1.32.

Is FibroBiologics, Inc. Common Stock overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of FibroBiologics, Inc. Common Stock (FBLG)?

The analyst target price is $19.00, representing +1339.4% upside from the current price of $1.32.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-5.03 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-419.40%

Beta1.11

50D MA$4.26

200D MA$7.65

Shares out0.00B

Float0.00B

Short ratio—

Avg volume1.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

FBLG vs LLY →FBLG vs JNJ →FBLG vs ABBV →Stock screener →